MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Early neurotransmitters changes in Parkinson’s disease with REM sleep behaviour disorder

    D. Urso, B. Tafuri, S. Nigro, V. Gnoni, I. Rosenzweig, K. Ray Chaudhuri, G. Logroscino (Tricase, Italy)

    Objective: In this study, we aimed to comprehensively investigate the early neurotransmitters changes in a cohort of de novo Parkinson's disease (PD) patients with and…
  • 2023 International Congress

    Melatonin for huntington disease (HD) gene carriers with HD-related sleep disturbance – a pilot study

    J. Patino, S. Zadegan, N. Rocha, N. Karagas, W. Tanigaki, B. Duncan, E. Furr Stimming (Houston, USA)

    Objective: To evaluate the efficacy of exogenous melatonin in improving sleep quality in Huntington disease (HD) gene carriers. Background: Various sleep disorders have been identified…
  • 2023 International Congress

    Detection of freezing of gait in people with Parkinson’s disease using novel deep learning approaches.

    EC. Klaver, IB. Heijink, G. Silvestri, JPP. van Vugt, J. Nonnekes, RJA. van Wezel, MC. Tjepkema-Cloostermans (Nijmegen, Netherlands)

    Objective: To detect freezing of gait (FOG) in people with Parksinson’s disease using three novel deep learning approaches. Background: FOG is one of the most…
  • 2023 International Congress

    Depression and Activities of Daily Living in Idiopathic Parkinson’s Disease without Dementia.

    L. Ortega, C. González, S. Otalvaro, J. Ayala (Cali, Colombia)

    Objective: Objective: To study the influence of depression on ADLs in patients with PD in stages I and II of Hoenh and Yahr. Background: Background:…
  • 2023 International Congress

    Deep Brain Stimulation Duration and Changes in Basal Ganglia Excitatory/Inhibitory Balance in Children and Young Adults with Dystonia

    T. Larsh, D. Gilbert, S. Vadivelu, S. Wu (Cincinnati, USA)

    Objective: We sought to explore associations between basal ganglia aperiodic signals and time since deep brain stimulation (DBS) implantation in children and young adults with…
  • 2023 International Congress

    Concordant RNA patterns in Parkinson’s disease brain and peripheral blood.

    K. Irmady, C. Hale, J. Fak, R. Qadri, T. Carroll, S. Przedborski, R. Darnell, S. Simelane (NEW YORK, USA)

    Objective: To investigate the molecular correlates of clinical heterogeneity in Parkinson’s disease (PD) in the striatum and peripheral blood. Background: The molecular basis for clinical…
  • 2023 International Congress

    Diabetic striatopathy presenting without hyperkinetic movements

    S. Bhalja, C. Sarvakar, S. Garg (Ahmedabad, India)

    Objective: To demonstrate a case of Diabetic striatopathy presenting without hyperkinetic movements Background: Diabetic striatopathy is an uncommon neurological complication associated with poorly controlled Diabetes Mellitus…
  • 2023 International Congress

    Screening risk of falls in Parkinson’s disease population living in underserved areas

    T. Capato, J. Miranda, F. Santos, R. Cury, E. Barbosa (São Paulo, Brazil)

    Objective: To verify the feasibility of the Balance-App to assess the risk of falls in the PD population living in underserved areas. Background: The screening…
  • 2023 International Congress

    The effect of dopaminergic medication on force fluctuation in Parkinson’s disease

    B. Afsharipour, M. Schindle, F. Roy, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify and compare muscle force variability during isometric dorsiflexion in male patients with Parkinson's Disease (PD), in the ON- versus OFF-medication state. Background:…
  • 2023 International Congress

    Individual-specific brain functional connectivity mapping of therapeutic response in task-specific focal dystonia

    E. Gordon, K. Matthews, A. Meyer, S. Norris (St. Louis, USA)

    Objective: Determine therapeutic effects of botulinum toxin on functional connectivity in individuals with task-specific dystonia. Background: Isolated task-specific dystonia occurs during specific activities, but not…
  • « Previous Page
  • 1
  • …
  • 319
  • 320
  • 321
  • 322
  • 323
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley